Switching from infliximab or etanercept to adalimumab in resistant or intolerant patients with spondyloarthritis: a 4-year study.

Switching from infliximab or etanercept to adalimumab in resistant or intolerant patients with spondyloarthritis: a 4-year study.

Item
http://www.wikidata.org/entity/Q51714523
Secukinumab for ankylosing spondylitis and psoriatic arthritisBiologic therapies in the treatment of psoriasis: a comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring.Spondyloarthritides: evolving therapiesPredictors of response and drug survival in ankylosing spondylitis patients treated with infliximab.Does the reason for discontinuation of a first TNF inhibitor influence the effectiveness of a second TNF inhibitor in axial spondyloarthritis? Results from the Swiss Clinical Quality Management Cohort.The role of adalimumab in rheumatic and autoimmune disorders: comparison with other biologic agentsPharmacoeconomic burden in the treatment of psoriatic arthritis: from systematic reviews to real clinical practice studies.Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides.Efficacy and safety of adalimumab in ankylosing spondylitis.The role of IL-17 in the treatment of psoriatic arthritis.A novel biological target for the treatment of psoriatic arthritis.Beyond anti-TNF-α agents in psoriatic arthritis.Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registry.Switching Between Biological Treatments in Psoriatic Arthritis: A Review of the Evidence.Unmet Needs in Axial Spondyloarthritis.
P2860

Switching from infliximab or etanercept to adalimumab in resistant or intolerant patients with spondyloarthritis: a 4-year study.

Item
http://www.wikidata.org/entity/Q51714523
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Switching from infliximab or e ...... dyloarthritis: a 4-year study.
@en
Switching from infliximab or e ...... dyloarthritis: a 4-year study.
@nl
type
label
Switching from infliximab or e ...... dyloarthritis: a 4-year study.
@en
Switching from infliximab or e ...... dyloarthritis: a 4-year study.
@nl
prefLabel
Switching from infliximab or e ...... dyloarthritis: a 4-year study.
@en
Switching from infliximab or e ...... dyloarthritis: a 4-year study.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Switching from infliximab or e ...... dyloarthritis: a 4-year study.
@en
P2093
P304
P31
P356
10.1093/RHEUMATOLOGY/KEQ008
P433
P478
P50
P577
P5875
P698
P921